AMEX:LABU   Direxion Daily S&P Biotech Bull 3X Shares
got out of LABD to buy LABU on next pullback down to about $88. 40 earnings growth and M&A optimism to reestablish in biotech/ healthcare. watching that ceiling of resistance to potentially pull profits